Croda International (LON:CRDA) Upgraded to Overweight at Morgan Stanley

Morgan Stanley upgraded shares of Croda International (LON:CRDAFree Report) to an overweight rating in a research note issued to investors on Wednesday morning, MarketBeat reports. The firm currently has GBX 3,350 price objective on the stock, up from their previous price objective of GBX 3,280.

Separately, Deutsche Bank Aktiengesellschaft lowered their price target on Croda International from GBX 3,100 to GBX 3,000 and set a “hold” rating for the company in a report on Tuesday. Three investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of GBX 3,140.

Get Our Latest Analysis on CRDA

Croda International Stock Up 0.1%

LON:CRDA opened at GBX 2,836 on Wednesday. The company has a debt-to-equity ratio of 31.85, a quick ratio of 2.25 and a current ratio of 1.99. The company has a market capitalization of £3.96 billion, a price-to-earnings ratio of 63.87, a price-to-earnings-growth ratio of 1.40 and a beta of 0.96. Croda International has a one year low of GBX 2,426.77 and a one year high of GBX 3,312. The stock has a 50-day simple moving average of GBX 2,843.37 and a 200 day simple moving average of GBX 2,779.62.

Croda International (LON:CRDAGet Free Report) last announced its quarterly earnings data on Tuesday, February 24th. The company reported GBX 146.20 earnings per share (EPS) for the quarter. Croda International had a return on equity of 2.82% and a net margin of 3.65%. Sell-side analysts predict that Croda International will post 181.8307268 EPS for the current fiscal year.

Insider Activity at Croda International

In related news, insider Steve Foots sold 3,622 shares of the stock in a transaction dated Tuesday, March 17th. The shares were sold at an average price of GBX 2,606, for a total transaction of £94,389.32. Also, insider Tom Brophy sold 1,020 shares of the stock in a transaction dated Tuesday, March 17th. The stock was sold at an average price of GBX 2,652, for a total transaction of £27,050.40. Insiders acquired a total of 766 shares of company stock valued at $2,136,858 in the last quarter. Insiders own 0.83% of the company’s stock.

About Croda International

(Get Free Report)

Founded in 1925 with the aim of turning bio-based raw materials into innovative ingredients, Croda International is a speciality chemicals company focused on consumer care and life sciences markets. The company is focused on creating, making and selling innovative ingredients that deliver real benefits to a diverse range of customers and employs more than 6,000 people around the world. Sustainability is a core part of the Groups strategy with a commitment to be Climate, Land and People positive by 2030.

Featured Articles

Analyst Recommendations for Croda International (LON:CRDA)

Receive News & Ratings for Croda International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Croda International and related companies with MarketBeat.com's FREE daily email newsletter.